• Cyclic di-GMP: Bridging Biofilm Stability and Immune Modulat

  2026-06-11

  Explore cyclic di-GMP as a pivotal intracellular second messenger at the intersection of bacterial persistence and immune modulation research. This article uniquely dissects its antitoxin mechanism, translational impact, and nuanced protocol considerations for advanced biomedical studies.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-06-10

  Oliveira et al. (2025) demonstrate that naturally occurring angiotensin peptides, including the Asp-Arg-Val-Tyr-Ile-His hexapeptide Angiotensin 1/2 (1-6), markedly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. This mechanistic insight suggests new avenues for investigating the intersection of the renin-angiotensin system, cardiovascular regulation, and viral pathogenesis.

• CTP Solution (100 mM) in mRNA-LNP Therapy: Biochemical Preci

  2026-06-10

  Explore the essential role of CTP Solution (100 mM) as a Cytidine-5'-triphosphate substrate in next-generation mRNA-LNP therapies. This article uniquely analyzes nucleotide integrity, biochemical selectivity, and translational performance for advanced RNA-based cancer treatments.

• HyperFluor 488 Goat Anti-Human IgG Antibody: Mechanism & Use

  2026-06-09

  The HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody is a polyclonal goat anti-human IgG antibody conjugated to Alexa Fluor 488, optimized for sensitive immunoassays. This dossier details its high specificity, broad application scope, and evidence-backed performance benchmarks.

• HOXC8 Suppresses Pyroptosis via Caspase-1 Regulation in NSCL

  2026-06-09

  The reference study identifies HOXC8 as a transcriptional suppressor of caspase-1, limiting pyroptotic cell death and promoting non-small cell lung carcinoma (NSCLC) progression. By elucidating a novel epigenetic mechanism linking HOXC8, HDAC1/2, and caspase-1, the research provides new insights into regulated cell death pathways in lung cancer and highlights directions for future therapeutic modulation.

• Dual Biosensing for Amatoxins and Phallotoxins in Mushrooms

  2026-06-08

  This study introduces a computationally guided approach to hapten design, enabling the creation of monoclonal antibodies for the simultaneous detection of lethal amatoxins and phallotoxins in mushrooms. The resulting dual-target fluorescent immunochromatographic assay achieves high sensitivity and practical utility, representing a significant advance for toxicology and public health.

• Polyploid Giant Cancer Macrophages: Markers of Tumor Progres

  2026-06-08

  This study provides a detailed phenotypic and clinical analysis of circulating polyploid giant cancer macrophages (CAMLs) in diverse solid tumors, revealing their strong correlation with disease progression and metastatic potential. By characterizing the cellular properties and clinical relevance of CAMLs, the research advances understanding of pre-metastatic niche formation and highlights new targets for monitoring cancer dynamics.

• Naringenin Modulates ER Stress to Reverse HCV-Induced Insuli

  2026-06-07

  The reference study demonstrates that naringenin counteracts hepatitis C virus (HCV)-induced insulin resistance by suppressing endoplasmic reticulum (ER) stress and downregulating the IRE1α/XBP1 pathway in hepatocytes. These mechanistic insights advance our understanding of metabolic dysfunction in HCV infection and highlight ER stress modulation as a potential target for therapeutic intervention.

• PFHxS Disrupts Lipid Homeostasis via PPARα in Zebrafish Mode

  2026-06-06

  The reference study demonstrates that environmentally relevant concentrations of perfluorohexanesulfonic acid (PFHxS) disrupt lipid homeostasis in zebrafish larvae through the activation of peroxisome proliferator-activated receptor alpha (PPARα). Using integrated lipidomic and transcriptomic profiling, the research identifies PPARα as a critical molecular target for PFHxS, and shows that pharmacological antagonism of PPARα rescues specific lipid disturbances. These findings clarify the mechanistic basis for PFAS-induced metabolic dysregulation and offer a robust in vivo model for future metabolic disease research.

• SB525334: Precision TGF-beta1 Receptor Inhibition in Fibrosi

  2026-06-05

  SB525334 stands out as a highly selective TGF-beta1 receptor inhibitor, empowering researchers to dissect TGF-beta signaling in advanced fibrosis and wound healing models. Its robust performance and reproducibility make it a go-to tool for mechanistic and translational studies requiring reliable pathway modulation.

• BRD4 Inhibitors Enhance Erastin-Induced Ferroptosis via ROS/

  2026-06-05

  This study establishes that BRD4 inhibition, including with I-BET-762, robustly enhances erastin-induced ferroptosis across diverse cell lines by promoting ROS accumulation and downregulating FSP1. The findings clarify the mechanistic interplay between BET inhibition and ferroptosis, offering new avenues for translational research in cancer biology.

• PPARγ Activation Modulates Macrophage Polarization in IBD Mo

  2026-06-04

  This study reveals that PPARγ activation, achieved with pioglitazone, shifts macrophage polarization from M1 to M2 phenotypes and ameliorates symptoms in a murine model of inflammatory bowel disease (IBD). Mechanistically, the work demonstrates that these effects are mediated through the STAT-1/STAT-6 signaling pathway, offering new insight for targeted immunomodulation in IBD research.

• GST-Mediated Resistance to Lambda-Cyhalothrin in M. usitatus

  2026-06-04

  This study reveals that glutathione S-transferase (GST) upregulation is a central mechanism conferring resistance to lambda-cyhalothrin in Megalurothrips usitatus, primarily by reinforcing antioxidant defenses. Functional inhibition of GST using diethyl maleate sharply increases insecticide susceptibility, providing mechanistic insight for resistance management and oxidative stress research.

• O-GlcNAcylation Rewires Glycolysis in Wnt-Driven Bone Format

  2026-06-03

  This study uncovers how Wnt3a signaling enhances O-GlcNAcylation to regulate glycolytic metabolism and promote bone formation by osteoblasts. The findings reveal a dual mechanism—both rapid and sustained—linking Wnt activity, PKA-mediated signaling, and glucose flux to key post-translational modifications central to osteogenesis.

• Quizartinib (AC220): Next-Gen Precision in FLT3-Driven AML A

  2026-06-03

  Explore how Quizartinib (AC220) empowers next-generation FLT3 autophosphorylation inhibition assays for acute myeloid leukemia (AML) research. This article delivers a uniquely practical analysis of selectivity, resistance, and biological context, surpassing standard reviews.

451 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page